Related Experiment Video
Updated: Feb 7, 2026

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
Phenotype analysis and clinical management in a large family with a novel truncating mutation in RASGRP2, the
Amrita Desai1, Wolfgang Bergmeier2, Mathias Canault3
1Division of Hematology/Oncology University of Miami Miami FL USA.
Insights
Novel genetic variants in RASGRP2 cause inherited bleeding disorders due to platelet defects. This study identifies a new mutation affecting CalDAG-GEFI, impacting platelet aggregation and offering insights for cardiovascular therapies.
Area of Science:
- Hematology
- Genetics
- Cardiovascular Medicine
Background:
- Genetic variants in RASGRP2, encoding CalDAG-GEFI, are linked to inherited bleeding disorders.
- CalDAG-GEFI is crucial for platelet aggregation and αIIbβ3 integrin activation.
- CalDAG-GEFI is a potential therapeutic target for cardiovascular disorders like arterial thrombosis.
Purpose of the Study:
- To characterize the phenotypical and clinical profiles of patients with CalDAG-GEFI deficiency.
- To investigate a novel truncating CalDAG-GEFI mutation within a five-generation family.
Main Methods:
- Clinical management and phenotypic variability were detailed for affected individuals.
- Whole exome sequencing identified a homozygous c.1490delT mutation in RASGRP2.
- Sanger sequencing confirmed the mutation in affected family members.
Main Results:
- Patients presented with severe mucocutaneous bleeding and post-surgical bleeding, unresponsive to platelet transfusions.
- Platelet aggregation to ADP and collagen was defective, with reduced αIIbβ3 integrin function.
- A novel homozygous truncating mutation (p.F497Sfs*22) in CalDAG-GEFI was identified.
Conclusions:
- The identified mutation causes a significant bleeding disorder linked to CalDAG-GEFI deficiency.
- Recombinant Factor VIIa showed efficacy in managing bleeding episodes.
- Further long-term studies are needed to fully understand CalDAG-GEFI's role in bleeding phenotypes and management.
Background:
Genetic variants in the RASGRP2 gene encoding calcium and diacylglycerol-regulated guanine nucleotide exchange factor I (CalDAG-GEFI) represent a new inherited bleeding disorder linked to major defects of platelet aggregation and activation of αIIbβ3 integrin. They are of major interest as CalDAG-GEFI is receiving attention as a potential target for antiplatelet therapy for prevention and treatment of cardiovascular disorders including arterial thrombosis and atherosclerosis.
Objectives:
To better understand the phenotypical and clinical profiles of patients with CalDAG-GEFI deficiency.
Patients:
We report a five-generation family with a novel truncating CalDAG-GEFI mutation detailing clinical management and phenotypic variability.
Results:
Patients IV.6 & IV.4 manifested with episodes of serious mucocutanous bleeding or bleeding after surgery not responding to platelet transfusion but responding well to recombinant Factor VIIa infusions. Their blood counts and coagulation parameters were normal but platelet aggregation to ADP and collagen was defective. Further work-up confirmed normal levels of αIIb and β3 in their platelets but decreased αIIbβ3 function. DNA analysis by whole exome sequencing within the BRIDGE-BPD consortium (Cambridge, UK), allowed us to highlight a homozygous c.1490delT predicted to give rise to a p.F497Sfs*22 truncating mutation near to the C-terminal domain of CalDAG-GEFI. Sanger sequencing confirmed that both patients were homozygous for the c.1490delT and 3 out of 4 close family members were heterozygous.
Conclusions:
A long-term prospective study is warranted for full clinical exploration of CalDAG-GEFI to understand the bleeding phenotyes and their management.
More Related Videos
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
10:40Comprehensive Workflow for the Genome-wide Identification and Expression Meta-analysis of the ATL E3 Ubiquitin Ligase Gene Family in Grapevine
Published on: December 22, 2017
Related Concept Videos
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Gene Families
Mutations
Protein Families
Truncation in Survival Analysis
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
Mutation, Gene Flow, and Genetic Drift